See also this year's filing and all EDGAR filings for this company.
PDF Report 0001662244_2022_Cyteir_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001662244, Cyteir Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 193,077,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,055,000 |
| 3 | remainder_Assets | 256,000 |
| 4 | LiabilitiesCurrent | 7,511,000 |
| 5 | LiabilitiesNoncurrent | 201,000 |
| 6 | remainder_Liabilities | 384,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,300,000 |
| 9 | ResearchAndDevelopmentExpense | 30,959,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 133,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 195,388,000 |
| 1 | Liabilities | 8,096,000 |
| 2 | Expenses | 42,259,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 187,292,000 |
| 5 | NetIncome | -42,126,000 |
| 6 | ComprehensiveNetIncome | -42,126,000 |
| 7 | BaseVar | 122,938,000 |
| 8 | EconomicCapitalRatio | 2.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
